Compare Abeona Therapeutics Inc (ABEO) vs iShares MSCI Taiwan ETF (EWT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs iShares MSCI Taiwan ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while iShares MSCI Taiwan ETF trades at $105.47. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, iShares MSCI Taiwan ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | EWT | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $7.45 | $111.53 |
52-Week Low | $4.17 | $58.05 |
Enterprise Value | $276.10M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →
